Search Results
May 05, 2026, 16:01 ET Rigel Reports First Quarter 2026 Financial Results
responses achieved with olutasidenib may be more durable. The longer duration of complete remission (CR) plus CR with partial hematologic recovery (CR+CRh) observed with olutasidenib may be clinically meaningful in a setting where sustained remissions are difficult to achieve. While indirect and non-confirmatory,
More news about: Rigel Pharmaceuticals, Inc.
Apr 23, 2026, 10:30 ET Construction Materials Market Size to Reach USD 1.7 Trillion by 2032, at a CAGR of 3.8% | Allied Market Research
infrastructure construction.Holcim — Sustainable building solution that include low-carbon cement and circular construction materials.CRH plc — An international group of diversified building materials products with operations mostly in North America and Europe.Sika AG — Makes chemical
More news about: Allied Market Research
Apr 20, 2026, 10:16 ET Construction Aggregates Market to Reach US$ 875.4 Billion by 2033 Driven by Infrastructure Expansion and Sustainable Material Adoption - Persistence Market Research
AfricaKey Players and Business StrategiesLeading players in the construction aggregates market include Holcim Ltd., CRH plc, Heidelberg Materials AG, Vulcan Materials Company, CEMEX S.A.B. de C.V., Martin Marietta Materials, and China National Building Material Company.
More news about: Persistence Market Research Pvt. Ltd.
Apr 17, 2026, 11:00 ET BougeRV Expands Portable Cooling Lineup with Feature-Rich CRD2 V2.0 and Compact CRH20 Fridges for On-the-Go Living
integrated wheels and handles for easy transport across campsites or worksitesCRH20: Compact, Fast-Cooling Convenience for Everyday UseDesigned for mobility and simplicity, the CRH20 Portable Fridge offers a compact yet powerful cooling solution ideal for shorter trips and daily
More news about: BougeRV
Apr 17, 2026, 06:45 ET Global Precast Concrete Market to Reach USD 261.5 Billion by 2035, Led by Asia Pacific Growth and Giants Like LafargeHolcim & CRH Plc
modular housing developmentsExpansion in emerging marketsCompetitive LandscapeLeading companies such as LafargeHolcim, CRH Plc, Cemex S.A.B. de C.V., Boral Limited, Forterra, Gulf Precast Concrete Co. LLC, Tindall Corporation, Skanska AB, Spancrete, and Gülermak A.Ş. are
More news about: Future Market Insights
Apr 06, 2026, 10:43 ET Precast Concrete Market to Surpass USD 186 Billion by 2031 Driven by Infrastructure Investments & Housing Demand | Mordor Intelligence Reports
Concrete Companies Balfour Beatty Boral Ltd. Bouygues Construction CEMEX S.A.B. de C.V. CRH ELO Beton Forterra Building Products Limited FP McCann Gulf Precast Holcim Larsen & Toubro
More news about: Mordor Intelligence Private Limited
Apr 02, 2026, 09:00 ET Carbon Upcycling secures $10M in financing from ATEL Ventures to support clean cement manufacturing
Climate Investment, Oxy Low-Carbon Ventures, Amplify Capital, and Clean Energy Ventures, as well as three of the world's leading cement manufacturers: CRH Ventures, Cemex Ventures, and TITAN Group. In recognition of its breakthrough technology, Carbon Upcycling has been named a three-time Global Cleantech
More news about: Carbon Upcycling Technologies Inc.
Mar 03, 2026, 09:00 ET Carbon Upcycling Appoints Suzy Taherian as CFO to Advance Global Commercialization
Climate Investment, Oxy Low-Carbon Ventures, Amplify Capital, and Clean Energy Ventures, as well as three of the world's leading cement manufacturers: CRH Ventures, Cemex Ventures, and TITAN Group. In recognition of its breakthrough technology, Carbon Upcycling has been named a three-time Global Cleantech
More news about: Carbon Upcycling Technologies Inc.
Feb 17, 2026, 07:45 ET TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
approved therapy, CR/CRh rates across the class are generally <25% and of short duration, underscoring the continued unmet medical need." Dr. Bianco continued, "Given the strong scientific rationale, we believe adding TBS-2025 to a menin inhibitor may markedly increase both the CR/CRh rate and its duration,
More news about: TuHURA Biosciences, Inc.
Feb 12, 2026, 09:00 ET Oldcastle APG Launches Innovative Outdoor Products and Solutions at International Builders' Show
oldcastleapg.com. About CRH CRH is the leading provider of building materials critical to modernizing infrastructure. With our team of 80,000 people across 4,000 locations,
More news about: Oldcastle APG
Feb 04, 2026, 09:00 ET Boomband Raises $4.0M to Reinvent the Talent Market and Restore Humanity in Hiring
CRH,
More news about: Boomband
Feb 03, 2026, 10:00 ET Catalyst™ Fence Solutions Unveils Contractor-First AR Tool and New Manchester Fence at FENCETECH 2026
CatalystFence.com.About Oldcastle® APG Oldcastle® APG, a CRH Company, is North America's leading provider of innovative outdoor living solutions that enable customers to Live Well Outside. The manufacturer's portfolio
More news about: Catalyst Fence Solutions
Feb 03, 2026, 09:00 ET Carbon Upcycling appoints Markus Kritzler as CEO to accelerate global commercialization
Climate Investment, Oxy Low-Carbon Ventures, Amplify Capital, and Clean Energy Ventures, as well as three of the world's leading cement manufacturers: CRH Ventures, Cemex Ventures, and TITAN Group. In recognition of its breakthrough technology, Carbon Upcycling has been named a three-time Global Cleantech
More news about: Carbon Upcycling Technologies Inc.
Jan 20, 2026, 12:30 ET Sakrete Celebrates 90-Year Legacy at World of Concrete 2026
oldcastleapg.com. About CRHCRH plc (NYSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing 80,000 people at over 3,800 operating locations in 28 countries, CRH has market leadership positions in North America
More news about: Sakrete
Jan 07, 2026, 12:30 ET Pebble Technology International Introduces PebbleTec Glass Tile
oldcastleapg.com. About CRH CRH plc (NYSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing 80,000 people at over 3,800 operating locations in 28 countries, CRH has market leadership positions in North America
More news about: Pebble Technology International
Jan 06, 2026, 16:30 ET CRH Ventures partners with Citylogix to accelerate digital transformation in road infrastructure management
towns as they modernize their road networks."About CRH Ventures CRH Ventures is the venture capital unit of CRH, the leading global provider of building materials. With access to CRH's Venturing and Innovation Fund, CRH Ventures partners with and invests ambitiously and strategically
More news about: CRH Ventures
Jan 06, 2026, 12:00 ET NORTHGATE READY MIX DRIVERS VOTE TO JOIN TEAMSTERS LOCAL 665
SANTA ROSA, Calif., Jan. 6, 2026 /PRNewswire/ -- Ready mix drivers at Northgate Ready Mix, a CRH company, in Santa Rosa and Sonoma have successfully won their card check election and joined the Teamsters. The newest members of Teamsters Local 665
More news about: International Brotherhood of Teamsters
Dec 08, 2025, 12:00 ET Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
had not received prior treatment with a menin inhibitor (n = 15), the objective response rate (ORR) was 73.3% and CR+CRh was 40%. Across the optimization dose levels, the duration of CR+CRh (n = 11) was 12.5 months and in all optimization patients (n = 39) median overall survival (mOS) was 11.8 months.For
More news about: Sumitomo Pharma America
Dec 05, 2025, 17:49 ET CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
AdditionCRH CRHMaterials
More news about: S&P Dow Jones Indices
Dec 05, 2025, 08:00 ET Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting
response evaluable (n=30), the overall response rate (ORR) was 87 percent, and the rate of complete remissions with full or partial hematologic recovery (CR/CRh) was 43 percent.Among patients receiving DXA scans across lines of therapy (n=56), 21 percent had low bone density at baseline. In this population,
More news about: Blueprint Medicines, a Sanofi company
Nov 20, 2025, 15:32 ET CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
www.peachtreemed.com. About CRH Healthcare CRH Healthcare, based in Atlanta, is a consumer- and quality-focused urgent care industry leader that helps patients Get in. Get
More news about: CRH Healthcare
Nov 17, 2025, 08:05 ET Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
a higher CR/CRh rate (41%), ORR (54%), and longer median OS (13 months) compared to those with ≥3 prior regimens (CR/CRh: 24%; ORR: 39%; median OS: 8.9 months). In the 12 patients that were R/R to prior venetoclax, 33% achieved a CR/CRh; median duration of CR/CRh was not reached
More news about: Rigel Pharmaceuticals, Inc.
Nov 05, 2025, 10:24 ET From Monitoring to Action: Intenseye Launches Sentinel, a Physical AI Hardware Suite for Real-Time Safety
response times, stronger collaboration between safety and operations teams, and a clear reduction in high-severity incidents At CRH Building Products (formerly Oldcastle APG), one of North America's largest building materials companies, the team first tested Intenseye's Hard Stop
More news about: Intenseye
Nov 03, 2025, 09:05 ET Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
treatment. A total of 71 patients (48%) achieved an overall response; 47 patients (32%) achieved CR and 51 (35%) achieved CR/CRh. Among CR/CRh responders, 28 (55%) achieved a response in <2 months, 17 (33%) from 2 to 4 months, and 6 (12%) at >4 months. Patients
More news about: Rigel Pharmaceuticals, Inc.
Nov 03, 2025, 09:00 ET Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
no dose-limiting toxicities (DLTs) in 116 patients with sustained complete remission (CR) and complete remission with partial hematologic recovery (CRh) seen at doses of 200, 300 and 400 mg BID. Given the wide therapeutic window of enzomenib, these findings suggest that dosing may be tailored to the
More news about: Sumitomo Pharma America